Journal of Hepatology最新文献

筛选
英文 中文
Does MASH Co-Morbidity in CHB Truly Suppress Immune Function? 慢性阻塞性肺病的 MASH 并发症真的会抑制免疫功能吗?
IF 25.7 1区 医学
Journal of Hepatology Pub Date : 2024-11-08 DOI: 10.1016/j.jhep.2024.11.002
Zhigang Wei, Dan Shan, Chaojie Liang
{"title":"Does MASH Co-Morbidity in CHB Truly Suppress Immune Function?","authors":"Zhigang Wei, Dan Shan, Chaojie Liang","doi":"10.1016/j.jhep.2024.11.002","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.11.002","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Author’s contributions</h2>Zhigang Wei: Study design &amp; Manuscript Writing.Dan Shan and Chaojie Liang: Study design &amp; Manuscript Revision.</section></section><section><section><h2>Declaration of Competing Interest</h2>We declare there is no any conflict of interest.</section></section><section><section><h2>Acknowledgements &amp; Funding</h2>This work was supported by Shanxi Medical University Doctoral Start-up Fund (XD1802) and Shanxi Scholarship Council of China (20221852).</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"94 1","pages":""},"PeriodicalIF":25.7,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142596807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic plasma exchange in acute liver failure: Challenges in patient selection and optimal timing of intervention 急性肝衰竭的治疗性血浆置换:患者选择和最佳干预时机的挑战
IF 25.7 1区 医学
Journal of Hepatology Pub Date : 2024-11-08 DOI: 10.1016/j.jhep.2024.10.036
Bikrant Bihari Lal, Seema Alam
{"title":"Therapeutic plasma exchange in acute liver failure: Challenges in patient selection and optimal timing of intervention","authors":"Bikrant Bihari Lal, Seema Alam","doi":"10.1016/j.jhep.2024.10.036","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.036","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Author’s contribution</h2>BBL prepared the first draft. SA critically reviewed and approved the final manuscript.</section></section><section><section><h2>Financial disclosure</h2>None</section></section><section><section><h2>Declaration of Competing Interest</h2>Bikrant Bihari Lal and Seema Alam declare no financial or non-financial conflict of interest.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"16 1","pages":""},"PeriodicalIF":25.7,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142597854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dysglycemia and liver lipid content influence the link between insulin resistance and liver mitochondrial function in obesity – Author’s reply 糖代谢异常和肝脏脂质含量影响肥胖症患者胰岛素抵抗与肝脏线粒体功能之间的联系 - 作者回复
IF 25.7 1区 医学
Journal of Hepatology Pub Date : 2024-11-08 DOI: 10.1016/j.jhep.2024.11.003
Sabine Kahl, Michael Roden
{"title":"Dysglycemia and liver lipid content influence the link between insulin resistance and liver mitochondrial function in obesity – Author’s reply","authors":"Sabine Kahl, Michael Roden","doi":"10.1016/j.jhep.2024.11.003","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.11.003","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Financial suppport</h2>The research of the authors is supported in part by grants from the German Federal Ministry of Health (BMG), the Ministry of Culture and Science of the State North Rhine Westphalia (MKW NRW) to DDZ, and the German Federal Ministry of Education and Research (BMBF) and the MKW NRW to German Center for Diabetes Research (DZD e. V.). The research of M.R. is supported by grants from the European Community (HORIZON-HLTH-2022-STAYHLTH-02-01: Panel A) to the INTERCEPT-T2D consortium, the German Science</section></section><section><section><h2>Author contributions</h2>S.K. drafted the manuscript. S.K. and M.R. revised and approve the final version of the manuscript. M.R. is the guarantor of this work, with full access to all data and analyses related to the content of this article.</section></section><section><section><h2>ClinTrials.gov identifier</h2>NCT01477957We thank Xiyin Yang and Qiang Hu for their interest in our article [1], which investigated the association of whole-body insulin sensitivity and hepatic OXPHOS capacity in people with obesity grade 3. We would like to take the opportunity to address their comments on our study.First, the prospective BARIA-DDZ study was designed to assess metabolic changes with one focus on different features of hepatic mitochondrial function in people with obesity. For this purpose, we developed a</section></section><section><section><h2>Declaration of Competing Interest</h2>M.R. received lecture fees or served on advisory boards for AstraZeneca, Echosens, Eli Lilly, Madrigal, Merck-MSD, Novo Nordisk and Target RWE and performed investigator-initiated research with support from Boehringer Ingelheim, Novo Nordisk and Nutricia/Danone to the German Diabetes Center (DDZ). No conflicts of interest, financial or otherwise, are declared by the other authors.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"18 1","pages":""},"PeriodicalIF":25.7,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142596804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to “Immune checkpoint inhibitor therapy for functional cure of hepatitis B in cancer patients: a promising strategy?” and “Hepatocellular Carcinoma Patients as an Ideal Study Population for Immune Checkpoint Inhibitors in Hepatitis B” 对 "免疫检查点抑制剂治疗癌症患者的乙型肝炎功能性治愈:一种前景广阔的策略?"和 "肝细胞癌患者是免疫检查点抑制剂治疗乙型肝炎的理想研究人群 "的回复
IF 25.7 1区 医学
Journal of Hepatology Pub Date : 2024-11-08 DOI: 10.1016/j.jhep.2024.10.045
Hsien-Chen Mon, Yi-Hsiang Huang
{"title":"Reply to “Immune checkpoint inhibitor therapy for functional cure of hepatitis B in cancer patients: a promising strategy?” and “Hepatocellular Carcinoma Patients as an Ideal Study Population for Immune Checkpoint Inhibitors in Hepatitis B”","authors":"Hsien-Chen Mon, Yi-Hsiang Huang","doi":"10.1016/j.jhep.2024.10.045","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.045","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Financial disclosure funding</h2>No financial support was received for this letter.</section></section><section><section><h2>Funding funding</h2>None</section></section><section><section><h2>Conflict-of-interest statement COI</h2>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</section></section><section><section><h2>Author contributions author-disclosure</h2>HCM: manuscript drafting; YHH: critical expert review and revision of the manuscript.</section></section><section><section><h2>Acknowledgements</h2>There are no additional acknowledgements.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"29 1","pages":""},"PeriodicalIF":25.7,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142596808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to: “Reassessing the causal association between frailty and chronic liver disease: Evidence from genetic analyses” 答复"重新评估虚弱与慢性肝病之间的因果关系:来自基因分析的证据"
IF 25.7 1区 医学
Journal of Hepatology Pub Date : 2024-11-07 DOI: 10.1016/j.jhep.2024.10.034
Qi Zhong, Hao-Wen Chen, Shun Zhang, Ji-Yuan Zhou, Xian-Bo Wu
{"title":"Reply to: “Reassessing the causal association between frailty and chronic liver disease: Evidence from genetic analyses”","authors":"Qi Zhong, Hao-Wen Chen, Shun Zhang, Ji-Yuan Zhou, Xian-Bo Wu","doi":"10.1016/j.jhep.2024.10.034","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.034","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Data availability statement</h2>GWAS summary statistics for frailty are available for download from the MRC-IEU GWAS database (<span><span>https://gwas.mrcieu.ac.uk/</span><svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"><path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"></path></svg></span>). Similarly, GWAS summary statistics for liver disease can be accessed through the FinnGen consortium (<span><span>https://r11.finngen.fi/</span><svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"><path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"></path></svg></span>).</section></section><section><section><h2>Authors’ contributions</h2>QZ, H-WC, and SZ drafted the manuscript and performed the main MR analyses. X-BW and J-YZ revised the manuscript. All authors reviewed and approved the final manuscript.</section></section><section><section><h2>Financial support</h2>This study was supported by the National Natural Science Foundation of China [grant numbers 82173607, 82173619], and the Guangdong Basic and Applied Basic Research Foundation [grant numbers 2021A1515011684, 2024A1515011969]. The funders had no role in study design, data collection or analysis, data interpretation, manuscript writing, or decision to submit the paper for publication.</section></section><section><section><h2>Declaration of Competing Interest</h2>The authors of this study declare that they do not have any conflict of interest.</section></section><section><section><h2>Acknowledgements</h2>GWAS summary statistics for frailty are available for download from the MRC-IEU GWAS database (<span><span>https://gwas.mrcieu.ac.uk/</span><svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"><path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"></path></svg></span>). Similarly, GWAS summary statistics for liver disease can be accessed through the FinnGen consortium (<span><span>https://r11.finngen.fi/</span><svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"><path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"></path></svg></span>).</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"61 1","pages":""},"PeriodicalIF":25.7,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142594321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to: “From mice to humans: Unravelling the genetic levers of NASH” [J Hepatol (2020) 749-751] 更正:"从小鼠到人类:揭示 NASH 的遗传杠杆" [J Hepatol (2020) 749-751] 更正
IF 25.7 1区 医学
Journal of Hepatology Pub Date : 2024-11-07 DOI: 10.1016/j.jhep.2024.10.002
Wajahat Zafar Mehal
{"title":"Corrigendum to: “From mice to humans: Unravelling the genetic levers of NASH” [J Hepatol (2020) 749-751]","authors":"Wajahat Zafar Mehal","doi":"10.1016/j.jhep.2024.10.002","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.002","url":null,"abstract":"It has come to our attention that the following text should have been included in the ‘Financial support’ section of this article: “Dr. Mehal has an appointment at the West Haven VA Medical Center and this work was supported by a US Department of Veterans Office of Research &amp; Development with grant BX003259-05A1”. We apologise for any inconvenience caused.","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"37 1","pages":""},"PeriodicalIF":25.7,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142594545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rethinking Methodology and Data Integrity in Mendelian Randomization: Insights from Air Pollution and MASLD Research 反思孟德尔随机化的方法和数据完整性:空气污染和 MASLD 研究的启示
IF 25.7 1区 医学
Journal of Hepatology Pub Date : 2024-11-06 DOI: 10.1016/j.jhep.2024.10.040
Junhao Chen, Haifeng Wang, Shi Fu
{"title":"Rethinking Methodology and Data Integrity in Mendelian Randomization: Insights from Air Pollution and MASLD Research","authors":"Junhao Chen, Haifeng Wang, Shi Fu","doi":"10.1016/j.jhep.2024.10.040","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.040","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Authors’ contributions</h2>Junhao Chen: conceptualization and manuscript draft. Haifeng Wang: supporting role in revision for important intellectual content. Shi Fu: critical revision for important intellectual content, final approval.</section></section><section><section><h2>Financial support</h2>None</section></section><section><section><h2>Declaration of Competing Interest</h2>The authors of this study declare that they do not have any conflict of interest.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"304 1","pages":""},"PeriodicalIF":25.7,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142588319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to: “Prediction of HBsAg loss after cessation of entecavir therapy” 答复"恩替卡韦治疗停止后 HBsAg 消失的预测"
IF 25.7 1区 医学
Journal of Hepatology Pub Date : 2024-11-06 DOI: 10.1016/j.jhep.2024.10.041
Rex Wan-Hin Hui, Lung-Yi Mak, Man-Fung Yuen
{"title":"Reply to: “Prediction of HBsAg loss after cessation of entecavir therapy”","authors":"Rex Wan-Hin Hui, Lung-Yi Mak, Man-Fung Yuen","doi":"10.1016/j.jhep.2024.10.041","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.041","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>AUTHOR CONTRIBUTIONS</h2>RWH Hui was involved in manuscript design and drafting of manuscript. LY Mak was involved in critical revision of manuscript. MF Yuen was involved in critical revision of manuscript and overall study supervision. The authors declare that they have participated in the preparation of the manuscript and have seen and approved the final version.</section></section><section><section><h2>DISCLOSURES/ CONFLICT OF INTEREST STATEMENT</h2>MF Yuen is an advisory board member and/or received research funding from AbbVie, Arbutus Biopharma, Assembly Biosciences, Bristol Myer Squibb, Dicerna Pharmaceuticals, GlaxoSmithKline, Gilead Sciences, Janssen, Merck Sharp and Dohme, Clear B Therapeutics, Springbank Pharmaceuticals; and received research funding from Arrowhead Pharmaceuticals, Fujirebio Incorporation and Sysmex Corporation. The remaining authors have no conflict of interests.</section></section><section><section><h2>DATA AVAILABILITY STATEMENT</h2>The data from this study is available from the corresponding author upon reasonable request.</section></section><section><section><h2>Funding</h2>Innovative Research Fund of the State Key Laboratory of Liver Research, The University of Hong Kong (ref. no.: SKLLR/IRF/2018/07) and the S. K. Yee Medical Foundation Grant (ref. no.: 2141213). The funders had no involvement in study design, data collection/ analysis/ interpretation, writing of the manuscript or decision to submit the article for publication.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"61 1","pages":""},"PeriodicalIF":25.7,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142588329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plasma exchange in Acute liver failure: The jury is still out! 急性肝衰竭的血浆置换:尚无定论!
IF 25.7 1区 医学
Journal of Hepatology Pub Date : 2024-11-06 DOI: 10.1016/j.jhep.2024.10.037
Sagnik Biswas, Shekhar Swaroop
{"title":"Plasma exchange in Acute liver failure: The jury is still out!","authors":"Sagnik Biswas, Shekhar Swaroop","doi":"10.1016/j.jhep.2024.10.037","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.037","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Financial disclosures funding</h2>None</section></section><section><section><h2>Conflicts of interest COI</h2>The authors declare no conflicts of interest</section></section><section><section><h2>Authors contributions author-disclosure</h2>SB and SS wrote the initial draft. S revised the paper. All authors approved the final manuscript.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"45 1","pages":""},"PeriodicalIF":25.7,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142594290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to make a decision for the use of plasma exchange in patients with acute liver failure? 如何决定对急性肝衰竭患者进行血浆置换?
IF 25.7 1区 医学
Journal of Hepatology Pub Date : 2024-11-06 DOI: 10.1016/j.jhep.2024.10.038
Xiang-Yu Han, Hui-ru Qi
{"title":"How to make a decision for the use of plasma exchange in patients with acute liver failure?","authors":"Xiang-Yu Han, Hui-ru Qi","doi":"10.1016/j.jhep.2024.10.038","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.038","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Financial support</h2>The author received no financial support to produce this manuscript.</section></section><section><section><h2>Authors’ contributions</h2>Xiang-Yu Han: manuscript writing; Hui-ru Qi: critical revision</section></section><section><section><h2>Declaration of Competing Interest</h2>The author declare no conflicts of interest.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"1 1","pages":""},"PeriodicalIF":25.7,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142588320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信